Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
featured
A Phase 2a, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea predominant Irritable Bowel Syndrome (IBS-D)

no history of inflammatory or immune-mediated GI disorders including, but not limited to, inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis, and celiac disease

  • 71 views
  • 20 Aug, 2019
  • 1 location
featured
A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

  • 196 views
  • 25 Mar, 2021
  • 1 location
A Double Blind Placebo Control Study to Assess the Safety Tolerability and Efficacy of Copaxone in Crohn's Disease

phase 2 study. Target disease: Crohn's disease. Rational and relevance to IBD patients: Copaxone is known for its high safety profile and for acting as an effective

budesonide
corticosteroids
mesalamine
clostridium difficile toxin
tumor necrosis factor alpha
  • 20 views
  • 07 Nov, 2020
  • 1 location
Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients

The investigator is hypothesize that an intensive FMT regimen will have superior efficacy the treatment of inflammatory disorders of the pouch (pouchitis and CLDP).

  • 0 views
  • 24 Jan, 2021
  • 1 location
A Study of E6011 in Participants With Active Crohn's Disease

The primary purpose of this study is to examine the efficacy and safety of E6011 after administration by means of double-blind placebo-controlled trial.

budesonide
small intestine
ciprofloxacin
sulfasalazine
azathioprine
  • 21 views
  • 04 Apr, 2021
  • 36 locations
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

The objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06651600 (200 mg for 8 weeks followed by 50 mg for 4 weeks) dosed once daily and PF-06700841 (60 mg for 12 weeks) dosed once daily during an induction period of 12 weeks, followed …

infliximab
ustekinumab
immunosuppressive agents
sulfasalazine
azathioprine
  • 1357 views
  • 24 May, 2021
  • 297 locations
Efficacy and Safety of TD-1473 in Crohn's Disease

A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease with up to 48 weeks of treatment.

tumor necrosis factor
conventional treatment
azathioprine
aminosalicylate
ulceration
  • 317 views
  • 28 Jan, 2021
  • 209 locations
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the efficacy of JNJ-active as measured by the change in the Crohn's Disease Activity Index (CDAI) score and Simplified Endoscopic Score for Crohn's disease (SES-CD) from baseline at Week 12.

infliximab
ustekinumab
azathioprine
mesalamine
crohn's disease
  • 84 views
  • 21 May, 2021
  • 151 locations
TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)

The purpose of this study is to evaluate the efficacy of TAK-018 in reducing endoscopic recurrence of intestinal inflammation in postoperative participants with CD after a planned laparoscopic ileocecal resection with primary anastomosis.

tumour necrosis
thiopurines
crohn's disease
tumor necrosis factor alpha
antibiotic therapy
  • 10 views
  • 13 Jun, 2021
  • 63 locations
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

. The total duration of the study participation, including extension and follow-up, will be approximately 26 weeks. With the wealth of scientific evidence on JAK/STAT involvement in IBD, the data

crohn's disease
remission
  • 72 views
  • 26 Jan, 2021
  • 81 locations